In summary, based on our in vitro and in vivo data, we identified in human GC an immunosuppressive pathway, which leads to CD45RA−CCR7− Treg subset induction by tumor-derived TNF-α and subsequent CD8+ T cells’ suppression and correlates with tumor progression and poor survival. This evidence concerns the gene CD8A and neoplasm.